RXII - .523 BZ: BioAxone in Collaboration with RXi Pharma is Awarded a $1.8M Grant from the National Institute of Neurological Disorders and Stroke BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury http://stockcharts.com/c-sc/sc?s=RXII&p=D&b=5&g=0&i=t62493031675&r=1505476570442 http://stockcharts.com/c-sc/sc?s=RXII&p=W&b=5&g=0&i=t73624743005&r=1505476556212